Annette Kent, BioInnovate Fellow 2015/16 and member of the Cardiothoracics team based in St James's Hospital, Dublin, is now Clinical Director with FIRE1. The company, headquartered in Dublin, is supported by The Foundry in California whose key focus is creating novel connected medical solutions dedicated to improving outcomes for people suffering with chronic disease. FIRE1's first product is an innovative monitoring solution to improve outcomes for Heart Failure patients. As Clinical Director, Annette is responsible for the development and implementation of the FIRE1 clinical programme, working very closely with key stakeholders, clinicians, advisors and trial sites. FIRE1 closed its Series C financing totalling €40 million in January 2018.